Exact Sciences Corporation - stock earnings
EXAS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 8, 2024 AfterMarket | -0.50 / -0.48 | - | 637.5 million / 639.9 million | - |
EXAS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -49.8 million USD | 646.9 million USD |
| 2023Q3 | 794000 USD | 628.3 million USD |
| 2023Q2 | -81.0 million USD | 622.1 million USD |
| 2023Q1 | -74.2 million USD | 602.5 million USD |
| 2022Q4 | -127.7 million USD | 553.0 million USD |
| 2022Q3 | -148.8 million USD | 523.1 million USD |
| 2022Q2 | -166.1 million USD | 521.6 million USD |
| 2022Q1 | -180.9 million USD | 486.6 million USD |
| 2021Q4 | -220.6 million USD | 473.8 million USD |
| 2021Q3 | -166.9 million USD | 456.4 million USD |
| 2021Q2 | -176.9 million USD | 434.8 million USD |
| 2021Q1 | -31.2 million USD | 402.1 million USD |
| 2020Q4 | -436.8 million USD | 466.3 million USD |
| 2020Q3 | -219.9 million USD | 408.4 million USD |
| 2020Q2 | -86.1 million USD | 268.9 million USD |
| 2020Q1 | -105.7 million USD | 347.8 million USD |
| 2019Q4 | 77.9 million USD | 295.6 million USD |
| 2019Q3 | -40.5 million USD | 218.8 million USD |
| 2019Q2 | -38.4 million USD | 199.9 million USD |
| 2019Q1 | -83.1 million USD | 162.0 million USD |
| 2018Q4 | -54.0 million USD | 143.0 million USD |
| 2018Q3 | -45.4 million USD | 118.3 million USD |
| 2018Q2 | -36.4 million USD | 102.9 million USD |
| 2018Q1 | -39.4 million USD | 90.3 million USD |
| 2017Q4 | -21.8 million USD | 87.4 million USD |
| 2017Q3 | -26.9 million USD | 72.6 million USD |
| 2017Q2 | -30.8 million USD | 57.6 million USD |
| 2017Q1 | -34.9 million USD | 48.4 million USD |
| 2016Q4 | -37.2 million USD | 35.2 million USD |
| 2016Q3 | -37.8 million USD | 28.1 million USD |
| 2016Q2 | -44.8 million USD | 21.2 million USD |
| 2016Q1 | -47.5 million USD | 14.8 million USD |
| 2015Q4 | -40.0 million USD | 14.4 million USD |
| 2015Q3 | -42.9 million USD | 12.6 million USD |
| 2015Q2 | -39.1 million USD | 8.1 million USD |
| 2015Q1 | -35.8 million USD | 4.3 million USD |
| 2014Q4 | -32.4 million USD | 1.5 million USD |
| 2014Q3 | -32.1 million USD | ? USD |
| 2014Q2 | -19.4 million USD | 294000 USD |
| 2014Q1 | -16.1 million USD | 294000 USD |
| 2013Q4 | -12.2 million USD | 1.0 million USD |
| 2013Q3 | -11.2 million USD | 1.0 million USD |
| 2013Q2 | -12.3 million USD | 1.0 million USD |
| 2013Q1 | -10.9 million USD | 1.0 million USD |
| 2012Q4 | -14.0 million USD | 1.0 million USD |
| 2012Q3 | -13.0 million USD | 1.0 million USD |
| 2012Q2 | -14.8 million USD | 1.0 million USD |
| 2012Q1 | -10.6 million USD | 1.0 million USD |
| 2011Q4 | -9.9 million USD | 1.0 million USD |
| 2011Q3 | -7.8 million USD | 1.0 million USD |
| 2011Q2 | -6.6 million USD | 1.0 million USD |
| 2011Q1 | -4.4 million USD | 1.0 million USD |
| 2010Q4 | -3.6 million USD | 1.4 million USD |
| 2010Q3 | -3.4 million USD | 1.4 million USD |
| 2010Q2 | -2.5 million USD | 1.3 million USD |
| 2010Q1 | -2.1 million USD | 1.3 million USD |
| 2009Q4 | -1.9 million USD | 1.2 million USD |
| 2009Q3 | -1.0 million USD | 1.3 million USD |
| 2009Q2 | -2.4 million USD | 1.3 million USD |
| 2009Q1 | -3.8 million USD | 1.0 million USD |
| 2008Q4 | -2.1 million USD | -1.9 million USD |
| 2008Q3 | -3.0 million USD | 337000 USD |
| 2008Q2 | -2.1 million USD | 51000 USD |
| 2008Q1 | -2.5 million USD | 51000 USD |
| 2007Q4 | -4.0 million USD | 537000 USD |
| 2007Q3 | -4.2 million USD | 113000 USD |
| 2007Q2 | -1.8 million USD | 1.1 million USD |
| 2007Q1 | -1.9 million USD | 1.2 million USD |
| 2006Q4 | -2.4 million USD | 1.2 million USD |
| 2006Q3 | -3.1 million USD | 1.2 million USD |
| 2006Q2 | -3.2 million USD | 1.2 million USD |
| 2006Q1 | -4.2 million USD | 1.2 million USD |
| 2005Q4 | -2.7 million USD | 1.2 million USD |
| 2005Q3 | -3.3 million USD | 1.2 million USD |
| 2005Q2 | -4.0 million USD | 623000 USD |
| 2005Q1 | -4.6 million USD | 1.2 million USD |
| 2004Q4 | -4.6 million USD | 1.3 million USD |
| 2004Q3 | -4.4 million USD | 1.3 million USD |
| 2004Q2 | -4.3 million USD | 1.2 million USD |
| 2004Q1 | -5.3 million USD | 1.2 million USD |
| 2003Q4 | -5.7 million USD | 1.2 million USD |
| 2003Q3 | -6.9 million USD | 918000 USD |
| 2003Q2 | -7.9 million USD | 406000 USD |
| 2003Q1 | -7.9 million USD | 408000 USD |
| 2002Q4 | -7.0 million USD | 408299 USD |
| 2002Q3 | -7.4 million USD | 409479 USD |
| 2002Q2 | -7.9 million USD | 39956 USD |
| 2002Q1 | -7.6 million USD | 39266 USD |
| 2001Q4 | -6.6 million USD | 37781 USD |
| 2001Q3 | -5.7 million USD | 13089 USD |
| 2001Q2 | -5.7 million USD | 1 USD |
| 2001Q1 | -5.4 million USD | 1 USD |
EXAS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -204.1 million USD | 2.5 billion USD |
| 2022 | -623.5 million USD | 2.1 billion USD |
| 2021 | -595.6 million USD | 1.8 billion USD |
| 2020 | -848.5 million USD | 1.5 billion USD |
| 2019 | -84.0 million USD | 876.3 million USD |
| 2018 | -175.1 million USD | 454.5 million USD |
| 2017 | -114.4 million USD | 266.0 million USD |
| 2016 | -167.2 million USD | 99.4 million USD |
| 2015 | -157.8 million USD | 39.4 million USD |
| 2014 | -100.0 million USD | 1.8 million USD |
| 2013 | -46.5 million USD | 4.1 million USD |
| 2012 | -52.4 million USD | 4.1 million USD |
| 2011 | -28.7 million USD | 4.2 million USD |
| 2010 | -11.6 million USD | 5.3 million USD |
| 2009 | -9.1 million USD | 4.8 million USD |
| 2008 | -9.7 million USD | -867000 USD |
| 2007 | -12.0 million USD | 2.9 million USD |
| 2006 | -12.9 million USD | 4.8 million USD |
| 2005 | -14.5 million USD | 4.3 million USD |
| 2004 | -18.5 million USD | 4.9 million USD |
| 2003 | -28.3 million USD | 2.9 million USD |
| 2002 | -29.9 million USD | 897000 USD |
| 2001 | -23.5 million USD | 50870 USD |
| 2000 | -11.9 million USD | 1 USD |
| 1999 | -5.0 million USD | ? USD |
| 1998 | -3.6 million USD | ? USD |
EXAS
Price: $59.48
52 week price:
Earnings Per Share: -1.13 USD
P/E Ratio: -39.52
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 953316
Ebitda: -23.0 millionMarket Capitalization: 11.4 billion